| # | Drug | Count |
|---|---|---|
| 0 | CYTARABINE | 5 |
| 1 | LENALIDOMIDE | 5 |
| 2 | METHOTREXATE | 5 |
| 3 | METHOTREXATE SODIUM | 5 |
| 4 | CARFILZOMIB | 4 |
| 5 | CYCLOPHOSPHAMIDE | 4 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 8 | DEXAMETHASONE | 4 |
| 9 | DEXAMETHASONE 1.5 MG | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALFUZOSIN HYDROCHLORIDE | 2 | 0.0008 |
| 1 | INOTUZUMAB OZOGAMICIN | 2 | 0.0007 |
| 2 | PIPERACILLIN AND TAZOBACTAM | 2 | 0.0002 |
| 3 | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | 1 | 0.0001 |
| 4 | CARFILZOMIB | 4 | 0.0001 |
| 5 | MESNA INJECTION | 1 | 0.0001 |
| 6 | MESNA | 1 | 0.0001 |
| 7 | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | 2 | 0.0001 |
| 8 | CYTARABINE | 5 | 0.0001 |
| 9 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 1 | Proteasome Inhibitor [EPC] | 4 | 0.0000 |
| 2 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 7 | Thalidomide Analog [EPC] | 5 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 2 | 0.0000 |